Verition Fund Management LLC Fibrogen Inc Call Options Transaction History

Verition Fund Management LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2020 Feb 16, 2021	BUY	$37.09 - $48.97 $463,625 - $612,125	12,500 Added 41.67%	42,500 $1.58 Million
Q3 2019 Nov 14, 2019	SELL	$36.98 - $48.45 $369,799 - $484,500	-10,000 Reduced 25.0%	30,000 $1.11 Million
Q2 2019 Aug 14, 2019	BUY	$35.13 - $55.53 $1.41 Million - $2.22 Million	40,000 New	40,000 $1.81 Million

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $31.9M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.